It is also notable that SGLT2 inhibitor versus DPP4 inhibitor initiation was associated with a lower dementia risk among those with BMI < 30 kg/m2, a subgroup containing some who are at a higher dementia risk in later life. Here, SLC5A2 is linked to dementia.